Novavax, Inc. (NVAX) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by, everyone. My name is Jim, and I'll be your conference operator for today. I would like to welcome everyone to the Novavax second quarter 2026 financial results and operational highlights conference call. All lines have been placed on a mute to prevent any background noise. After today's speaker's remarks, there will be a question and answer session. If you would like to ask a question during that time, simply press star followed by the number one on your telephone keypad. And if you would like to withdraw your question, simply press star and one again. Thank you. It's now my pleasure to turn the floor over to Naina Zeman. You may begin. Good morning, and thank you all for joining us today to discuss our second quarter financial results and operational highlights today on August 6, 2026. A press release announcing our results is available on our website at www.novavax.com and an audio archive of this conference call will be available on our website later today. Before we begin with prepared remarks, I would like to remind you that this presentation includes forward-looking statements regarding Novavax's current expectations related to, but not limited to, its partnerships, market opportunities, and financial guidance. Our actual results may be materially different from such statements as detailed in the presentation. Discussions of non-GAAP figures and reconciliations to GAAP figures are available in our earnings press release and descriptions of the risks and uncertainties associated with Novavax are included in our SEC filings. Both can be accessed through our website. Joining me today are John Jacobs, our president and CEO, Jim Kelly, our chief financial officer, Elaine O'Hara, chief strategy officer, and Dr. Bob Walker, head of R&D. I wo...